FIELD: medicine. SUBSTANCE: method involves administering beta-form of methyl uracil to an experimental animal at a dose of 20 mg/kg of animal body weight. EFFECT: enhanced effectiveness of the method. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
SOLID MEDICINAL FORM - TABLETS WITH ELEUTHEROCOCCUS SENTICOSUS | 1992 |
|
RU2057527C1 |
METHOD OF INSPECTION OF BIOLOGICAL NON-EQUIVALENCE OF CHEMICALLY IDENTICAL MEDICINES | 1990 |
|
RU2027185C1 |
SUBSTANCE SHOWING RADIOPROTECTIVE EFFECT | 1993 |
|
RU2104007C1 |
METHOD FOR AMPLIFYING ANTITUMORAL EFFECT OF EXPERIMENTAL RADIOTHERAPY | 1993 |
|
RU2044545C1 |
COMPOSITION SHOWING ANTIMICROBIAL EFFECT | 1993 |
|
RU2061476C1 |
LOCAL ANESTHETIC OPHTHALMIC REMEDY | 1992 |
|
RU2038076C1 |
ANTITUMOR REMEDY | 1993 |
|
RU2034543C1 |
LOTION FOR HAND CARE | 2000 |
|
RU2161950C1 |
SUSPENDED METHYLURACIL FORMULATION | 1992 |
|
RU2007998C1 |
COMPOSITION SHOWING ANTIMICROBIAL EFFECT | 1993 |
|
RU2061472C1 |
Authors
Dates
1996-07-10—Published
1993-02-19—Filed